This Article  • Full text  • PDF  • JAMA News Video  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (148)  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Sexually Transmitted Diseases  • Dermatology  • Women's Health  • Papillomavirus, Human  • Women's Health, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Eileen F. Dunne, MD, MPH; Elizabeth R. Unger, PhD, MD; Maya Sternberg, PhD; Geraldine McQuillan, PhD; David C. Swan, PhD; Sonya S. Patel, BS; Lauri E. Markowitz, MD

JAMA. 2007;297:813-819.

Context  Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection. Baseline population prevalence data for HPV infection in the United States before widespread availability of a prophylactic HPV vaccine would be useful.

Objective  To determine the prevalence of HPV among females in the United States.

Design, Setting, and Participants  The National Health and Nutrition Examination Survey (NHANES) uses a representative sample of the US noninstitutionalized civilian population. Females aged 14 to 59 years who were interviewed at home for NHANES 2003-2004 were examined in a mobile examination center and provided a self-collected vaginal swab specimen. Swabs were analyzed for HPV DNA by L1 consensus polymerase chain reaction followed by type-specific hybridization. Demographic and sexual behavior information was obtained from all participants.

Main Outcome Measures  HPV prevalence by polymerase chain reaction.

Results  The overall HPV prevalence was 26.8% (95% confidence interval [CI], 23.3%-30.9%) among US females aged 14 to 59 years (n = 1921). HPV prevalence was 24.5% (95% CI, 19.6%-30.5%) among females aged 14 to 19 years, 44.8% (95% CI, 36.3%-55.3%) among women aged 20 to 24 years, 27.4% (95% CI, 21.9%-34.2%) among women aged 25 to 29 years, 27.5% (95% CI, 20.8%-36.4%) among women aged 30 to 39 years, 25.2% (95% CI, 19.7%-32.2%) among women aged 40 to 49 years, and 19.6% (95% CI, 14.3%-26.8%) among women aged 50 to 59 years. There was a statistically significant trend for increasing HPV prevalence with each year of age from 14 to 24 years (P<.001), followed by a gradual decline in prevalence through 59 years (P = .06). HPV vaccine types 6 and 11 (low-risk types) and 16 and 18 (high-risk types) were detected in 3.4% of female participants; HPV-6 was detected in 1.3% (95% CI, 0.8%-2.3%), HPV-11 in 0.1% (95% CI, 0.03%-0.3%), HPV-16 in 1.5% (95% CI, 0.9%-2.6%), and HPV-18 in 0.8% (95% CI, 0.4%-1.5%) of female participants. Independent risk factors for HPV detection were age, marital status, and increasing numbers of lifetime and recent sex partners.

Conclusions  HPV is common among females in the United States. Our data indicate that the burden of prevalent HPV infection among females was greater than previous estimates and was highest among those aged 20 to 24 years. However, the prevalence of HPV vaccine types was relatively low.

Author Affiliations: Centers for Disease Control and Prevention, Atlanta, Ga (Drs Unger and Swan, and Ms Patel); and National Center for Health Statistics, Centers for Disease Control and Prevention, Bethesda, Md (Dr McQuillan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

HPV Prevalence and Transmission
Tyler Cymet
JAMA. 2007;298(1):38.
EXTRACT | FULL TEXT  

HPV Prevalence and Transmission—Reply
Eileen Dunne and Lauri Markowitz
JAMA. 2007;298(1):38.
EXTRACT | FULL TEXT  

RELATED ARTICLES

HPV Prevalence and Transmission—Reply
Eileen Dunne and Lauri Markowitz
JAMA. 2007;298(1):38.
EXTRACT | FULL TEXT  

Estimating the Population Prevalence of HPV
Susan C. Weller and Lawrence R. Stanberry
JAMA. 2007;297(8):876-878.
EXTRACT | FULL TEXT  

Human Papillomavirus Infection
Janet M. Torpy, Alison E. Burke, and Richard M. Glass
JAMA. 2007;297(8):912.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The EVER Proteins as a Natural Barrier against Papillomaviruses: a New Insight into the Pathogenesis of Human Papillomavirus Infections
Lazarczyk et al.
Microbiol. Mol. Biol. Rev. 2009;73:348-370.
ABSTRACT | FULL TEXT  

The Moral Justification for a Compulsory Human Papillomavirus Vaccination Program
Balog
Am. J. Public Health 2009;99:616-622.
ABSTRACT | FULL TEXT  

Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States
Wheeler et al.
JNCI J Natl Cancer Inst 2009;101:475-487.
ABSTRACT | FULL TEXT  

Human Papillomavirus Quadrivalent Vaccine: A Look Behind The Numbers
Flaherty and Alkhateeb
The Annals of Pharmacotherapy 2009;43:740-744.
ABSTRACT | FULL TEXT  

Can Routine Posttransplant HPV Vaccination Prevent Commonly Occurring Epithelial Cancers after Allogeneic Stem Cell Transplantation?
Savani et al.
Clin. Cancer Res. 2009;15:2219-2221.
ABSTRACT | FULL TEXT  

Vaginal Self-Swab Specimen Collection in a Home-Based Survey of Older Women: Methods and Applications
Lindau et al.
J Gerontol B Psychol Sci Soc Sci 2009;0:gbn021v1-gbn021.
ABSTRACT | FULL TEXT  

Human Papillomavirus Vaccine Safety in Pediatric Patients: An Evaluation of the Vaccine Adverse Event Reporting System
Borja-Hart et al.
The Annals of Pharmacotherapy 2009;43:356-359.
ABSTRACT | FULL TEXT  

Infectious Agents and Colorectal Cancer: A Review of Helicobacter pylori, Streptococcus bovis, JC Virus, and Human Papillomavirus
Burnett-Hartman et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2970-2979.
ABSTRACT | FULL TEXT  

Prevalence, Acquisition, and Clearance of Cervical Human Papillomavirus Infection among Women with Normal Cytology: Hawaii Human Papillomavirus Cohort Study
Goodman et al.
Cancer Res. 2008;68:8813-8824.
ABSTRACT | FULL TEXT  

Ethics and the HPV Vaccine: Considerations for School Nurses
Bennett
The Journal of School Nursing 2008;24:275-283.
ABSTRACT | FULL TEXT  

The Pediatrician's Role in Preventing Cervical Cancer
Blatter and Monk
CLIN PEDIATR 2008;47:627-638.
 

Health and Economic Implications of HPV Vaccination in the United States
Kim and Goldie
NEJM 2008;359:821-832.
ABSTRACT | FULL TEXT  

Prevalence of Genital Human Papilloma Virus Infection and Genotypes among Young Women in Sicily, South Italy
Ammatuna et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2002-2006.
ABSTRACT | FULL TEXT  

Assessing Mandatory HPV Vaccination: Who Should Call the Shots?
Javitt et al.
J Law Med Ethics 2008;36:384-395.
 

Human Papillomavirus and Vaccination
Huang
Mayo Clin Proc. 2008;83:701-707.
ABSTRACT | FULL TEXT  

Pilot Study of Prevalence of High-Risk Human Papillomavirus Genotypes in Israeli Jewish Women Referred for Colposcopic Examination
Grisaru et al.
J. Clin. Microbiol. 2008;46:1602-1605.
ABSTRACT | FULL TEXT  

Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections
Rodriguez et al.
JNCI J Natl Cancer Inst 2008;100:513-517.
ABSTRACT | FULL TEXT  

Seroprevalences of Herpes Simplex Virus Type 2, Five Oncogenic Human Papillomaviruses, and Chlamydia trachomatis in Katowice, Poland
Gorander et al.
CVI 2008;15:675-680.
ABSTRACT | FULL TEXT  

Human Papillomavirus Infection and Cervical Cytology in Women Screened for Cervical Cancer in the United States, 2003-2005
Datta et al.
ANN INTERN MED 2008;148:493-500.
ABSTRACT | FULL TEXT  

Human Papillomavirus Vaccine Legislation in Kentucky: A Policy Analysis
Dekker
Policy Politics Nursing Practice 2008;9:40-49.
ABSTRACT  

Human Papillomavirus Infections in Primary Care
Ogunmodede et al.
Clin Med Res 2007;5:210-217.
ABSTRACT | FULL TEXT  

Demographic and Pathologic Differences in the Incidence of Invasive Penile Cancer in the United States, 1995-2003
Goodman et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1833-1839.
ABSTRACT | FULL TEXT  

Additional Health Care Visits Needed Among Adolescents for Human Papillomavirus Vaccine Delivery Within Medical Homes: A National Study
Rand et al.
Pediatrics 2007;120:461-466.
ABSTRACT | FULL TEXT  

HPV Vaccines Prophylactic, Not Therapeutic
Markowitz
JAMA 2007;298:805-806.
FULL TEXT  

HPV Prevalence and Transmission
Cymet
JAMA 2007;298:38-38.
FULL TEXT  

JournalWatch
Arch. Dis. Child. 2007;92:650-651.
FULL TEXT  

Mandatory HPV Vaccination: Public Health vs Private Wealth
Gostin and DeAngelis
JAMA 2007;297:1921-1923.
FULL TEXT  

Circumcision in the Time of HIV: When Is There Enough Evidence to Revise the American Academy of Pediatrics' Policy on Circumcision?
Dickerman
Pediatrics 2007;119:1006-1007.
FULL TEXT  

Life saving treatment or giant experiment?
Coombes
BMJ 2007;334:721-723.
FULL TEXT  

HPV Infection in U.S. Women: Who Has the Highest Prevalence?
JWatch Women's Health 2007;2007:3-3.
FULL TEXT  

Human Papillomavirus Prevalence in the U.S.
JWatch Pediatrics 2007;2007:1-1.
FULL TEXT  

High Prevalence of HPV in U.S. Females
JWatch Emergency Med. 2007;2007:2-2.
FULL TEXT  

HPV Prevalence in U.S. Women
JWatch General 2007;2007:1-1.
FULL TEXT  

Estimating the Population Prevalence of HPV
Weller and Stanberry
JAMA 2007;297:876-878.
FULL TEXT